Cerebral Palsy Research Program Authorization Act of 2025
- Sponsor
- Rep. Cohen, Steve [D-TN-9]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Mar 18, 2025
Bottom line
This bill seeks to expand federal research, surveillance, and educational efforts specifically targeting cerebral palsy, aiming to improve understanding, diagnosis, treatment, and prevention of the condition.
What it actually does
This bill authorizes the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to establish and carry out a comprehensive program of research related to cerebral palsy. This program would include research on diagnosis, treatment, prevalence mitigation, and the health care and societal costs of cerebral palsy, alongside public health surveillance and educational initiatives for health professionals and the general public. The bill authorizes $5,000,000 to be appropriated for each of fiscal years 2026 through 2031 to fund these activities.
Proponents argue
Supporters argue that cerebral palsy is a widespread and costly condition affecting over a million Americans, with significant gaps in understanding its causes and best practices for care. They contend that dedicated federal research, surveillance, and education programs are crucial to finding treatment breakthroughs, preventing types of cerebral palsy, and reducing the substantial lifetime care and productivity costs associated with the disorder, as highlighted by the bill's findings.
Opponents contend
Critics might argue that while the intent is laudable, existing federal health research bodies already have mechanisms to fund research into various conditions, and creating a new, specifically authorized program might lead to fragmentation or inefficient allocation of resources compared to a more integrated approach. Some might also question the specific funding level or whether it diverts resources from other critical health research areas.
The bill is very short and clearly written, making it highly accessible for any reader to understand its provisions quickly.
Section 3, inserting new section 317C-1 into Title III of the Public Health Service Act.
Establishment of a Cerebral Palsy Research Program
This provision directs the Secretary of Health and Human Services, primarily through the Centers for Disease Control and Prevention (CDC), to create and implement a research program focused on cerebral palsy. The program will investigate better ways to diagnose and treat cerebral palsy, identify factors that could reduce its occurrence, analyze its economic burden, conduct public health surveillance, and develop educational materials for both medical professionals and the general public about the condition. It also authorizes $5 million annually for fiscal years 2026 through 2031 to fund these activities.
Supporters argue
Supporters argue that this dedicated program is essential to address the significant knowledge gaps and high societal costs associated with cerebral palsy. They believe focused research will accelerate breakthroughs in prevention and treatment, ultimately improving outcomes for affected individuals and their families, as well as reducing the economic burden on the healthcare system.
Critics contend
No specific organized opposition is typically raised against medical research funding for specific conditions, especially those with high prevalence and impact. However, some might argue for broader, disease-agnostic research funding mechanisms to allow for more flexible allocation based on scientific priority rather than condition-specific mandates.
Tradeoffs
The primary tension involves balancing dedicated funding for a specific condition like cerebral palsy against the broader needs of public health research and the flexibility of general research funding. While targeted funding ensures attention to a specific area, it might be seen by some as potentially diverting resources from other critical, but less specifically legislated, health challenges.